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The subventricular zone (SVZ) of the lateral ventricles
is the largest neurogenic niche of the postnatal brain.
New SVZ-generated neurons migrate via the rostral
migratory stream to the olfactory bulb (OB) where
they functionally integrate into preexisting neuronal
circuits. Nonsynaptic GABA signaling was previously
shown to inhibit SVZ-derived neurogenesis. Here we
identify the endogenous protein diazepam binding
inhibitor (DBI) as a positive modulator of SVZ post-
natal neurogenesis by regulating GABA activity in
transit-amplifying cells. We performed DBI loss-
and gain-of-function experiments in vivo at the peak
of postnatal OB neuron generation in mice and
demonstrate that DBI enhances proliferation by
preventing SVZ progenitors to exit the cell cycle.
Furthermore, we provide evidence that DBI exerts
its effect on SVZ progenitors via its octadecaneuro-
peptide proteolytic product (ODN) by inhibiting
GABA-induced currents. Together our data reveal
a regulatory mechanism by which DBI counteracts
the inhibitory effect of nonsynaptic GABA signaling
on subventricular neuronal proliferation.
INTRODUCTION
The majority of neurons are born during embryonic development
in restricted progenitor zones and neuroblasts migrate along
specific pathways to reach their final destination in the brain.
There is ample evidence, however, that neurogenesis, migration,
and subsequent integration of new neurons into preexisting
networks persists postnatally in several brain structures. In
rodents there are three neurogenic zones in the early postnatal
period: the subventricular zone (SVZ) of the lateral ventricles,
the subgranular zone of the hippocampal dentate gyrus (DG),
and the cerebellum (Hatten, 1999). In the SVZ and DG, neuro-
genesis continues throughout adulthood, albeit at a lower level
(Abrous et al., 2005). The largest fraction of SVZ-derived neurons
migrate anteriorly via the rostral migratory stream (RMS) to their
destination, the olfactory bulb (OB), where they mature into local76 Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc.GABAergic interneurons (Lois and Alvarez-Buylla, 1994; Luskin,
1993) and, to a minor extent, into glutamatergic neurons (Brill
et al., 2009). In young animals, a small fraction of neuroblasts
from the SVZ migrate also to other cortical areas (Bandeira
et al., 2009; Inta et al., 2008). Postnatal neurogenesis contributes
to structural plasticity in mature cortical circuits and affects OB-
and hippocampus-dependent learning and memory (Deng et al.,
2010; Lledo et al., 2008).
The SVZ comprises different cell types. Astrocyte-like stem
cells give rise to transit-amplifying cells (fast proliferating pro-
genitors) that in turn give rise to immature neurons (neuroblasts)
(Doetsch et al., 1999). Newly generated neurons migrate
in chains in the RMS that is ensheathed by processes of
astrocyte-like cells (Lois and Alvarez-Buylla, 1994). Postnatal
progenitors have specific intrinsic properties that in conjunction
with distinct environmental cues govern their proliferation,
migration, and differentiation into defined neuronal subtypes.
Over the last years, a number of molecular signals involved in
postnatal neurogenesis have been identified (Abrous et al.,
2005; Cayre et al., 2009). Of these, neurotransmitters received
special attention (Platel et al., 2010). For instance, nonsynaptic
GABA signaling via GABAA receptors was shown to regulate
in vitro and in vivo neural stem cell proliferation in the SVZ
(Fernando et al., 2011; Liu et al., 2005). However, little is known
about how GABA signaling is modulated by intrinsic or extrinsic
factors that might differentially affect distinct cell types in the
neurogenic niche.
GABAA receptors are heteropentameric ion channels that are
prevalently but not exclusively expressed at the cell surface on
multiple cell types of the CNS (D’Hulst et al., 2009). The activity
of GABAA receptors can be altered by a plethora of intrinsic
modulators including neurosteroids, endozepines, and zinc
(Bormann, 1991; Lambert et al., 2003; Smart et al., 2004). We
found it striking that the endozepine diazepam binding inhibitor
(DBI) is highly expressed in the SVZ and RMS (http://mouse.
brain-map.org/experiment/show/68632649). DBI is a small cyto-
solic protein (10 kDa) that is secreted to the extracellular space
via a nonconventional secretory pathway (Abrahamsen and
Stenmark, 2010) and binds to both central and peripheral-type
benzodiazepine receptors (CBRs andPBRs, respectively) (Costa
and Guidotti, 1991). The cloning and molecular characterization
of GABAA receptor subunits revealed that the CBR is in fact part
of the receptor. The CBR is identical to the benzodiazepine
binding site of the GABAA receptor and is located extracellularly
Figure 1. DBI Localization in Progenitor Cells from the SVZ/RMS
(A) Overview of the SVZ and posterior RMS in a sagittal brain section of
a mouse (P8) stained with antibodies against DBI (red). In the inset the marked
area indicates the brain region shown in the picture.
(B) DBI+ cells (red) colocalize with the astrocytic/neural stem cell marker GFAP
(blue) and Nestin (green) in the SVZ. The arrows indicate triple-positive stem
cells and the arrowhead indicates a DBI/GFAP double-positive astrocyte,
negative for Nestin.
(C and D) DBI immunoreactivity (red) is also detected in transit-amplifying cells
labeled with Mash1 (green in C) but not in DCX+ neuroblasts (green in D) from
the RMS. The arrows in (C) indicate double-positive cells.
Cx, cortex; LV, lateral ventricle; RMS, rostral migratory stream. Scale bars
represent 20 mm. See also Figure S1.
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complex, on the other hand, is localized mainly in the mitochon-
drial membrane in cells of the CNS and peripheral organs.
Expression in the brain is restricted to glial and ependymal cells
(Bormann, 1988; Papadopoulos et al., 2006). The full-length DBI
is the precursor of octadecaneuropeptide (ODN) and triakontate-
traneuropeptide (TTN), which also have a high affinity for diaz-
epam receptors (Slobodyansky et al., 1989).
In this study we investigated the function of the endozepines in
the SVZ-RMS in vivo at the peak time of OB-neuron generation
(Bayer, 1983; Hinds, 1968) and identified a mechanism by which
they modify GABA signaling thereby affecting postnatal sub-
ventricular neurogenesis.
RESULTS
DBI Expression in the SVZ/RMS
Expression of DBI and of its processing product ODN was found
in several brain areas and was reported in previous studies (Alho
et al., 1988; Tong et al., 1991; Tonon et al., 1990; Yanase et al.,
2002). Accordingly, we detected DBI expression in glial cells
from cortical areas and ependymal cells lining the ventricle but
not in mature neurons (not shown). Focusing on the SVZ and
RMS, we detected DBI in astrocyte-like GFAP/Nestin+ stem cells
and in Mash1+ fast dividing progenitors, but not in DCX+
migrating neuroblasts in young mice (Figures 1A–1D). It thus
appears that DBI is expressed at early stages of neurogenesis,
subsiding already at the neuroblast stage. A similar expression
pattern for DBI was found in the adult brain (Figure S1 available
online). Expression levels slightly decreased over time but the
cell type-specific expression pattern of DBI was not altered
during postnatal development. Although the majority of
Mash1+ cells were positive for DBI during the first postnatal
week (67% ± 1.2%, mean value ± SEM, n = 4mice), we detected
DBI in a smaller subset of Mash1+ cells in adult animals (32% ±
2.2%, mean value ± SEM, n = 6 mice).
In Vivo Knockdown of DBI in the SVZ Reduces Neuronal
Proliferation
To investigate the functional role of DBI in the SVZ, we performed
in vivo knockdown experiments. We used two shRNAs (short
hairpin RNA) sequences (a and b) for which the efficiency of
DBI silencing was first confirmed by western blot analysis of
transfected cell cultures (Figures S2A and S2B). To specifically
target newborn neurons, we performed retroviral injections in
the SVZ and established that DBI knockdown silenced DBI
expression in vivo (Figures S2C and S2D). The nature of the
retrovirus guarantees the exclusive infection of dividing cells
(mainly fast dividing progenitors) that give rise to neurons
(Ming and Song, 2005). Infected cells expressing knockdown
shRNA were positive for the Tomato protein whereas control
cells expressing scrambled shRNA were EGFP positive. To
control for differences resulting from individual variability and
differences in the injection site, P4-old mice were injected with
a mix of control (green) and DBI-knockdown (red) viruses (Fig-
ure 2A). We determined the total number of infected cells at 2,
4, and 7 days postinjection (dpi) and found that the ratio of red/
green cells decreased over time (Figures 2A and 2B). Two
scenarios could account for these results: DBI knockdownresulted in either increased cell death or reduced cell prolifera-
tion. The former could be excluded because active caspase-3
stainings revealed no difference in the number of apoptotic cells
between the DBI-knockdown and control population when
measured at 2 and 7 dpi (Figures S2E and S2F).Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc. 77
Figure 2. DBI Knockdown In Vivo Reduces
Proliferation of Newborn Neurons
(A) Mice were injected with a mix of shRNA
scrambled-EGFP (control, green) and shRNA DBI-
tomato-expressing retrovirus (red) into the SVZ.
2, 4, and 7 dpi, red and green cells were found in
the SVZ (1), RMS (2), and OB (3), respectively.
(B) Quantification of the total number of red/green
cells at different time points after the viral infection,
mean values (+SEM) from 5–6 mice per time point
(9,835 and 1,145 control and knockdown cells,
respectively), p < 0.0005 one-way ANOVA, **p <
0.01, ***p < 0.001 (post-hoc Tukey’s test, 4 or 7 dpi
versus 2 dpi).
(C) Left: Mice were injected with BrdU 2–3 days
after viral infection and killed 12 days later.
Quantification of BrdU+ cells in the control (black
bar) and knockdown DBI cell population (gray bar)
in the OB. The graph shows mean values (+SEM)
for 6 mice (1,609 and 822 control and knocked
down cells, respectively); ***p < 0.0001 (two-
tailed, unpaired t test) for shRNAa, and 7mice (608
and 763 control and knocked down cells, re-
spectively), **p < 0.005 (two-tailed, unpaired t test)
for shRNAb. Right: Confocal picture of the OB of
one injected mouse, showing differentiated neu-
rons infected with the viral mix stained for BrdU
(blue). Arrowheads indicate examples of control-
infected neurons (green) positive for BrdU and
arrows point to knockdown cells (red) labeled
with BrdU.
(D) Sagittal brain section of a mouse injected with
the viral mix at P4 and sacrificed 7 days post-
infection, showing immature migrating cells in the
RMS and differentiated neurons in the OB infected
with the green or red virus (enlargements on the
right).
(E) The graph shows mean values (+SEM) of the
ratio of red/green cells in the RMS (black bars) and
OB (gray bars), n = 16 mice (11,245 and 3,106
control and knocked down cells, respectively)
for shRNA DBIa, **p < 0.001 (two-tailed Mann
Whitney test); n = 13mice (1,700 and 1,251 control
and knocked down cells, respectively) for shRNA
DBIb, *p < 0.01 (two-tailed unpaired t test).
(F) Confocal picture of the RMS of an injected
animal, showing cells infected with the viral mix
stained for Mash1 (cyan), at 3 dpi. Arrows indicate
examples of control-infected progenitors positive
for Mash1.
(G) Quantification of Mash1+ cells in the control
(black bar) and knockdown DBI cell population
(gray bar). The graph shows mean values (+SEM)
for seven mice (1,568 and 1,264 control and
knockdown cells, respectively), **p < 0.001 (two-
tailed, paired t test).
Scale bars represent 20 mm. See also Figures
S2–S4.
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SVZ niche, we injected the control and DBI-knockdown viral
mix into the SVZ of P4-old mice followed by intraperitoneal injec-78 Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc.tions of the thymidine analog BrdU, a marker for dividing cells.
Twelve days postinjection we determined the number of BrdU-
positive neurons in the OB in DBI knockdown and control
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DBI Induces Neurogenesis via GABAA Receptorsneurons (Figure 2C). The percentage of BrdU+ cells was sig-
nificantly lower in the DBI-knockdown neuronal population
compared to controls, indicating that DBI expression in dividing
cells promotes proliferation. To further verify the specificity of the
DBI knockdown effect, we rescued DBI expression in shRNA-
DBI-infected cells with a retroviral vector containing the DBI
coding sequence linked to a fluorescent marker via a T2A self-
cleaving peptide (Figure S3A; Szymczak et al., 2004). Given
that the shRNA-DBIb sequence matches the 30UTR in DBI
mRNA, the exogenous DBI coding sequence expressed by the
virus was not a target for silencing (Figure S3B). Importantly,
neuronal proliferation measured by BrdU uptake was signifi-
cantly higher in double-infected cells coexpressing the knock-
down and rescue construct compared to knockdown only
(Figures S3C–S3E), indicating that a restoration of DBI levels
sufficed to rescue impaired proliferation.
Quantitative evaluation of DBI knockdown at 7 dpi revealed
differences along the SVZ-RMS-OB axis. Thus, the proportion
of cells that had reached the OB was higher in DBI-knockdown
cells compared to control (Figures 2D and 2E). Because the
majority of retrovirally infected cells in the SVZ are transit-
amplifying cells and neuroblasts (Rogelius et al., 2005) and DBI
was not detected in neuroblasts, it is unlikely that the higher
proportion of DBI-knocked down cells in the OB was the result
of faster neuroblast migration. Indeed, live imaging experiments
indicated that neuroblasts infected with control and shRNA-DBI
virus migrated at comparable speed (Figure S4 and Movie S1).
Alternatively, knockdown of DBI in neuronal progenitors may
reduce the time they spend in proliferation by promoting faster
differentiation to migrating neuroblast. Thus, DBI knockdown
cells would be detected in the OB before the controls. Such
a scenario is supported by the finding that 3 days postinjection,
the proportion of Mash1+ progenitor cells was significantly lower
upon DBI knockdown compared to control (Figures 2F and 2G).
DBI In Vivo Overexpression Promotes Proliferation
by Expanding Mash1+ Population
To further substantiate that DBI affects proliferation, we
performed gain-of-function experiments in vivo. To compare
overexpressing with control-infected cells, we mixed the DBI-
overexpressing virus with the retrovirus coding only for EGFP
(Figure 3A). We injected the viral mix into the SVZ of P4-old
mice and analyzed the ratio of red/green cells at three time points
(2, 4, and 7 dpi). The results showed that the proportion of red
cells increased over time, suggesting that DBI-overexpressing
cells proliferate more than control cells (Figure 3B). Thus, DBI
gain- and loss-of-function experiments had opposite effects.
To directly test that DBI promotes neuronal proliferation, we
analyzed the number of BrdU-containing cells in the virus-
infected population. As shown in Figure 3C, the percentage of
BrdU+ neurons was higher upon DBI overexpression, indicating
that DBI expression stimulates the proliferation of neural SVZ
progenitor cells.
We next analyzed the distribution of infected cells in the
RMS/OB at 7 dpi and found that the ratio of red/green cells
was significantly higher in the RMS than in the OB (Figures 3D
and 3E). The possibility that neuroblasts overexpressing DBI
might die before reaching the OB was ruled out because the
number of apoptotic cells was comparable to controls at 4 dpi(1.08% ± 0.27% and 1.11% ± 0.43% activated caspase-3-
positive cells, mean ± SEM from 2 animals, 667 and 421 control
and DBI-overexpression, respectively). Instead, a likely explana-
tion for this result is that DBI-overexpressing progenitors remain
in division for a longer time in comparison to controls, and hence
more time is required for these cells to differentiate to neuro-
blasts and to eventually reach the OB. Such a scenario is in
line with our findings that the number of Mash1-positive cells
was augmented after DBI overexpression (Figures 3F and 3G).
In summary, overexpressing and knockdown experiments
support the conclusion that DBI is a positive regulator of subven-
tricular neurogenesis.
DBI Knockdown Induces Cell Cycle Exit without
Affecting Cell Cycle Length in Dividing SVZ Progenitors
We subsequently investigated whether the effects of DBI on
proliferation resulted from an alteration of the cell number reen-
tering the cell cycle and/or the cell cycle length. We carried out
in vivo experiments by using two analogs of BrdU (IdU and
CldU) and measured the cell fraction remaining in division after
DBI knockdown. We first injected IdU to label the virus-infected
cells in S phase, and 12–20 hr later we performed multiple CldU
injections (every 2 hr) to label cells that divided again in the next
cycle. Thus, double-labeled cells reentered a new cell cycle
continuing to divide, whereas cells labeled only with the first
marker exited the cell cycle and stopped dividing (Figure 4A).
The results showed that among actively cycling cells, fewer
DBI-knockdown cells were double labeled with IdU/CldU in
comparison to control cells, indicating that DBI silencing induces
cell cycle exit (Figures 4B and 4C). This result was confirmed by
an alternative approach, where virus-infected cells were labeled
with BrdU, and 22 hr later the brains were fixed and stained for
the proliferation marker Ki67 (Figure S5). Thus, after DBI knock-
down, the proportion of cells reentering the cell cycle was
reduced by about 40%.
To investigate whether DBI expression might affect also the
cell cycle length, we used a short-interval IdU/CldU double
labeling approach (Figure 4D; Fukumitsu et al., 2006; Martynoga
et al., 2005; Quinn et al., 2007; Teissier et al., 2011) that allows
the estimation of the S phase (Ts) and the total cell cycle (Tc)
length (see Experimental Procedures). The Ts (4.78 ± 0.28 and
4.83 ± 0.24 hr, mean values ± SEM for control and DBI-knock-
down, respectively) and Tc (15.59 ± 0.79 and 15.36 ± 1.07 hr,
mean values ± SEM for control and DBI-knockdown, respec-
tively) values for the two groups were similar (Figures 4E
and 4F). In summary, DBI-knockdown does not affect the dura-
tion of the cell cycle in proliferating cells but dramatically reduces
the proportion of cells reentering the cell cycle.
DBI Acts via Central Benzodiazepine Receptors
The enhanced postnatal neuronal proliferation induced by DBI
raised the question whether this effect was mediated via the
central or peripheral benzodiazepine receptor. Hence, we em-
ployed SVZ primary cultures in which neural progenitors from
postnatal brain were allowed to proliferate and form neuro-
spheres. We expressed either DBI-RFP or only a control gene
(RFP) and analyzed the number of dividing (BrdU+) cells within
primary neurospheres (Figure 5A). In agreement with the in vivo
experiments, DBI enhanced cell proliferation in SVZ-derivedCell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc. 79
Figure 3. DBI Overexpression Induces
Neuronal Proliferation In Vivo
(A) Mice were injected into the SVZ with a control
(green) plus a DBI-overexpressing retrovirus (red).
2, 4, and 7 dpi, red and green cells were found in
the SVZ (1), RMS (2), and OB (3), respectively.
(B) Quantification of the total number of red/green
cells at different time points after the viral infection,
mean values (+SEM) from 4–6 mice per time point
(11,272 and 8,424 control and overexpressing
cells, respectively), p < 0.0005 one-way ANOVA,
**p < 0.01, ***p < 0.001 (post-hoc Tukey’s test, 4 or
7 dpi versus 2 dpi).
(C) Left: 2 and 3 days after virus infection, mice
were injected with BrdU and sacrificed 4 days
later. The graph shows the quantification of control
(black bar) and DBI-overexpressing neurons (gray
bar) positive for BrdU, expressed as a percentage
for each group. Mean values (+SEM) for 9 mice
(540 and 2,396 control and overexpressing cells,
respectively), **p < 0.0001 (two-tailed, unpaired
t test). Right: Confocal picture showing infected
neurons (green and red) that reached the OB,
colabeled with BrdU (blue). Arrowhead indicates
an example of control-infected cell (green) positive
for BrdU and arrows point to DBI-overexpressing
neurons (red) colabeled with BrdU.
(D) Overview of a sagittal brain section from a
mouse injected into the SVZ with the viral mix and
sacrificed 7 days after injection. On the right:
enlargements of the RMS and OB areas indicated
at left.
(E) Quantification of the ratio of red/green cells
in the RMS (black bar) and the OB (gray bar). Mean
values (+SEM) from 15 mice (3,728 and 7,860
control and overexpressing cells, respectively),
***p < 0.00001 (two-tailed unpaired t test).
(F) Infected mice were sacrificed 3 days after viral
injection and stained for Mash1 (cyan). Arrows
indicate examples of DBI-overexpressing cells
positive for Mash1.
(G) Quantification of Mash1+ cells in the SVZ for
control (black bar) and DBI-overexpressing cells
(gray bar). Mean values (+SEM) for 6 mice (1,058
and 1,216 control and overexpressing cells,
respectively), **p < 0.005 (two-tailed, paired t test).
Scale bars represent 20 mm.
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CBR or PBR antagonists flumazenil and PK-11195, respectively,
and found that DBI-induced proliferation could be blocked by80 Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc.flumazenil but not by PK-11195, suggest-
ing that DBI acts mainly via the CBR,
hence the GABAA receptor (Figure 5B).
The presence of both GABA and GABAA
receptors in SVZ-neurospheres was pre-
viously established (Fernando et al.,
2011). Interestingly, treatment of RFP-
infected neurospheres with flumazenil
reduced the number of BrdU+ cells in
comparison to RFP+ untreated cells,
whereas DBI-infected cells treated with
flumazenil showed no difference to RFP+untreated cells. These results suggest that the effect of
endogenous DBI might be blocked by flumazenil and that this
reduction can be reversed with the addition of exogenous DBI.
Figure 4. DBI Knockdown Increases the Cell Fraction Exiting the Cell Cycle
(A) To estimate the cell fraction that remains in the cell cycle, mice were injected with DBI-knockdown-tomato (shRNA DBIa) and control-EGFP virus into the SVZ
followed by IdU (white) and CldU (dark blue) i.p. injections according to the scheme. IdU/CldU double-labeled cells (light blue) are the ones that reenter the cell
cycle, whereas cells that exit the cell cycle are labeled only with IdU (white).
(B) Quantification of the IdU/CldU+ cell population as a fraction of all IdU+ cells for control (black bar) and DBI-knockdown (gray bar) infected cells in the SVZ. The
graph shows the mean values (+SEM) for 9 mice (436 and 298 control and knockdown cells, respectively), ***p < 10E7 (two-tailed, unpaired t test).
(C) Representative picture from the SVZ of a mouse injected with DBI knockdown-tomato virus (red), control-EGFP virus (green), IdU (white), and CldU (blue).
Bottom right: overview of the SVZ area containing the enlarged area shown in the other pictures. The arrow indicates a control-infected cell positive for IdU and
CldU and the arrowhead a IdU-positive and CldU-negative DBI-knockdown cell.
(D) To estimate the time cells spent in S phase, infected mice with the control and knockdown viral mix were subjected to IdU (white) and CldU (blue) injected
according to the scheme. During this short interval (2 hr), IdU is still present in the blood, hence CldU+ cells are also labeled with IdU (light blue). The cells that left S
phase after the 1.5 hr interval are labeled only with IdU (white).
(E) Ts was calculated via the formula Ts = (IdU+CldU+ cells)/(single IdU+ cells)3 1.5 hr, and Tc was calculated with the formula Tc = Ts/(IdU+CldU+ cells)3 total
number of proliferating cells. The fraction of mitotically active cells was determined based on Ki67 stainings. The graph shows Ts and Tc values obtained for each
experimental group, mean values (+SEM) for 10 mice (1,184 and 632 control and DBI-knockdown cells, respectively).
(F) Representative image of a SVZ section from amouse injectedwith DBI-knockdown (red), control virus (green), IdU (white), and CldU (blue). The arrow indicates
a IdU/CldU double-positive control-infected and the arrowhead a IdU/CldU double-positive DBI-knockdown-infected. Bottom right: Representative picture of
virally infected cells (control in green and DBI-knockdown in red) positive for Ki67 (blue) (arrowheads indicate examples of double-labeled cells).
LV, lateral ventricle. Scale bars represent 20 mm. See also Figure S5.
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Earlier studies showed that the DBI proteolytic fragments ODN
and TTN prefer different binding sites. Whereas ODN has
a high affinity for the benzodiazepine site of GABAA receptors
(sensitive to flumazenil), TTN preferentially binds to PBRs and
can displace PK-11195, but not flumazenil (Slobodyansky
et al., 1989). Our pharmacological results suggest that the short
peptide ODN might be the mediator of the above-described DBI
effect on neuroblast proliferation. Therefore, we tested whether
ODN has an effect on SVZ neurogenesis. To this end we gener-
ated an ODN-overexpression retrovirus that expressed also RFP(Figures 5C and 5D). Mice were injected into the SVZ with a mix
of control (green) and ODN-overexpressing virus (red), and we
analyzed in vivo proliferation of SVZ-generated neurons by per-
forming BrdU labeling experiments. Overexpression of ODN
induced neuronal proliferation as reflected by the higher number
of BrdU+ neurons in the OB in comparison to control (Figure 5E).
Furthermore, we examined the cell distribution of red and green
cells along the SVZ-RMS-OB axis at 7 dpi. This analysis revealed
that ODN-overexpressing cells required longer time to reach the
OB than control-infected cells (Figure 5F). In conclusion, ODN
replicated the results obtained when overexpressing full-lengthCell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc. 81
Figure 5. DBI Acts via GABAA Receptors and ODN Reproduces DBI
Effects In Vivo
(A and B) Neurosphere cultures from the SVZ of P8–P12 mice were infected
with either control (only RFP) or RFP-DBI-overexpressing virus. Both groups
were incubated with either media (control), the CBR antagonist flumazenil, or
the PBR antagonist PK-11195. All groups were subsequently incubated with
BrdU, and the number of BrdU-positive cells/neurosphere area was calcu-
lated. Scale bar represents 20 mm.
(B) Mean values (+SEM) from 95 to 118 neurospheres per group, from 2
experiments. p < 10E52 one-way ANOVA, **p < 0.001, *p < 0.01 (Bonferroni’s
Multiple Comparison post hoc analysis). All values were normalized to the RFP
control mean value. Since flumazenil itself inhibited proliferation, we first
normalized DBI-flumazenil values to RFP-flumazenil values to compare
between DBI-untreated and DBI-flumazenil and tested with one-way ANOVA,
##p < 0.001.
(C) Scheme of DBI and ODN peptides; ODN contains amino acids 33–50 of the
DBI protein.
(D) Scheme of the viral vectors used for in vivo infections.
(E) Mice were infected at P4with control (green) andODN-overexpressing (red)
retroviral mix followed by BrdU injections 2 and 3 days postinfection. The
graph shows the percentage of BrdU+ neurons in the OB for control and
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82 Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc.DBI, suggesting that ODN mediates DBI effects on subventricu-
lar progenitors.ODN Inhibits GABA-Induced Currents in Transit-
Amplifying Cells
Depending on the receptor subunit composition, endozepines
can act as positive or negative modulators of GABAA receptors
(reviewed in D’Hulst et al., 2009). Whereas the presence of
GABAA receptors was demonstrated in stem-like cells and
neuroblasts (Liu et al., 2005; Wang et al., 2003), there is no infor-
mation regarding their expression in transit-amplifying cells.
Therefore, we investigated first whether fast dividing progenitors
have functional GABAA receptors, and second, whether ODN
can modulate GABA-induced responses. We injected a retro-
virus expressing RFP into the SVZ of transgenic mice in which
migrating neuroblasts express EGFP, using the 5-HT3A-EGFP
mouse line described before (Figure 6A; Inta et al., 2008). Fast
dividing progenitors were identified based on the presence
of red fluorescence (newborn cells infected with retrovirus)
and the absence of green signal (neuroblast) as well as cell
morphology and location. Indeed, immunostainings on brain
sections from these experiments confirmed that virtually every
virally infected cell negative for EGFP in the SVZ expressed
Mash1 (Figure 6B). There were other infected cells also negative
for EGFP that did not express Mash1; however, these were glial
cells close to the injection site and clearly distinguishable from
transit-amplifying cells based on their morphology (not shown).
Two to five days after injection, we selected fast dividing
progenitors based on the above-mentioned criteria for electro-
physiological recordings. We recorded from these cells via
the whole-cell patch-clamp configuration (Figure 6C). EGFP/
RFP+ cells were hyperpolarized at rest (Vrest = 86.8 ± 5.9 mV,
n = 7). Their input resistance was 1.79 ± 0.46 GU (Figure 6D),
distinct from the input resistance of stem cells and ependymal
cells reported previously (30–40 MU) and from the input resis-
tance of neuroblasts in the SVZ and RMS (4 GU) (Lacar
et al., 2010). GABAA receptor-mediated currents in transit-
amplifying cells were studied in voltage-clamped nucleated
outside-out patches. Brief applications of GABA at a nondesen-
sitizing concentration (50 mM) via a piezo-driven two-barrelled
fast application system elicited inward currents with an ampli-
tude of 76.1 ± 20.6 pA. In the presence of ODN (20 mM),
GABAAR-mediated currents were significantly decreased, and
after washing out ODN, currents recovered to nearly control
values (Figures 6E and 6F). These results demonstrate that
ODN inhibits GABAA receptors in transit-amplifying cells. A
scheme showing the proposed link between DBI-modulated
GABA signaling and progenitor proliferation is presented in
Figure 7.ODN-overexpressing groups. Mean values (+SEM) from 10 mice (2,420 and
471 cells for control and overexpression, respectively), ***p < 0.00001 (two-
tailed, unpaired t test).
(F) P4 mice were injected into the SVZ with the viral mix and brain sections
were analyzed 1 week after infection. The graph shows the ratio of red/green
cells in the RMS (black bar) and the OB (gray bar). Mean values (+SEM) from
9 mice (20,399 and 1,396 cells for control and overexpression, respectively),
**p < 0.001 (two-tailed, unpaired t test).
Figure 6. ODN Reduces GABA-Induced
Currents in Transit-Amplifying Cells
(A) A retrovirus expressing RFP was injected into
the SVZ of 5-HT3A-EGFP transgenic mice where
neuroblasts are labeled in green.
(B) Four days after injection, virally infected cells
(red) in the SVZ that are not positive for 5-HT3A
(green) express Mash1 (blue).
(C) Example of patch-clamped transit-amplifying
cell (white arrow). The cell does not express EGFP
(green) but expresses RFP (red). Right picture:
bright-field image showing the position of the
patch-clamp pipette (black arrow).
(D) Current responses to 20mV voltage steps (from
40mV to +140mV) in the cell shown in (C)
recorded in voltage-clamp, showing high input
resistance and absence of voltage-sensitive Na+
current.
(E) Inward currents (average of eight traces
for each condition) obtained in response to fast
application of GABA or GABA+ODN in a voltage-
clamped nucleated outside-out patch from an
EGFP/RFP+ cell. Pale blue bars indicate the time
of application of GABA or GABA+ODN.
(F) Quantification of the results exemplified in
(E), mean values +SEM (n = 7 cells); **p < 0.01,
one-way repeated-measure ANOVA and post-hoc
Tukey’s test.
Scale bars represent 20 mm.
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In this study we have identified DBI as a key modulator of post-
natal neurogenesis in the largest proliferative area of the rodent
brain, the SVZ. We provide evidence that this protein acts in vivo
as a positive regulator for neuronal proliferation by reducing
GABA signaling. Ambient GABA in the SVZ niche was shown
to derive from neuroblasts and it was proposed that it provides
a feedback mechanism acting as a paracrine stop signal for
neuronal proliferation (Nguyen et al., 2003; Wang et al., 2003).
We show here that DBI produced by neuronal progenitors coun-
terbalances this effect by reducing GABA activity. Furthermore,
our results indicate that the effect of DBI on GABAA receptors
is exerted via its processing peptide ODN.
Immunostainings on sagittal brain sections containing the
RMS showed that DBI is synthesized in stem cells and fast
dividing progenitors but not in neuroblasts or mature neurons.
This expression pattern is consistent with the role we propose
for DBI on neuronal generation. Neural stem cells constitute
a small proportion of subventricular cells (0.4%) that have
a very slow turnover (few weeks) in contrast to transit-amplifying
cells, whose cell cycle lasts only few hours (Morshead et al.,
1998; Morshead and van der Kooy, 1992). It is therefore reason-
able to assume that the majority of retrovirus-infected cells
correspond to the fast dividing cell type. There was a significantCell Stem Cell 10, 76–difference (40%) of BrdU-labeled cells
between control and DBI-knockdown or
overexpression cells, indicating that a
large proportion of cells were affected
by the virus expression. Hence, our re-
sults point toward an effect on fast prolif-erating cells. In addition, possible effects on DBI manipulation in
stem cells would not be observed after such short time periods
that were used in this study (i.e., 3 to 12 days). However, it is likely
that DBI/ODN acts also on neural stem cells because they
express both DBI and GABAA receptors. Although neuroblasts
do not express DBI, they contain functional GABAA receptors
whose activity can also be inhibited by ODN (data not shown).
Given that stem cells, transit-amplifying cells, and astrocytes
are in close proximity to neuroblasts in the RMS and can secrete
DBI/ODN to the extracellular space, it is possible that paracrine
ODN affects migrating cells as well.
The cell cycle experiments demonstrated that DBI keeps
progenitor cells in division preventing cell cycle exit. Symmetric
division of transit-amplifying cells is a key determinant in regu-
lating the pool size of neural progenitors. After several rounds
of symmetric divisions, progenitors undergo asymmetric division
and eventually develop into neuroblasts (Takahashi et al., 1996).
A plethora of extracellular and intracellular factors have been
identified that regulate the cell cycle during development, tipping
the balance from proliferation to differentiation and thus ulti-
mately controlling the production of neurons (Caviness et al.,
2009; Mitsuhashi and Takahashi, 2009). In contrast, the literature
pertaining to factors modulating cell cycle kinetics during
postnatal neurogenesis is scarce (Doetsch et al., 2002; Zhang
et al., 2008). Overexpression and knockdown experiments87, January 6, 2012 ª2012 Elsevier Inc. 83
Figure 7. Expression and Effects of DBI/ODN in the SVZ of Postnatal
Mice
Neural stem cells and transit-amplifying cells express and release DBI to the
extracellular space where it is processed to ODN. Neuroblasts synthesize and
secrete GABA, which induces inward Cl currents through GABAA receptors
on neural progenitors and inhibits their proliferation by favoring their differ-
entiation to neuroblasts. At the same time, ODN also binds to GABAA recep-
tors, reducing GABA-evoked currents and resulting in increased proliferation.
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eration by affecting the mode of cell division. Thus, low levels of
DBI in progenitor cells favored the differentiation to migrating
neuroblasts, whereas high DBI expression expanded the popu-
lation of proliferating progenitors. Altered cell division would also
explain the early arrival to the OB of DBI-knockdown cells as
a result of reduced proliferation, and conversely delayed arrival
of DBI-overexpressing cells resulting from enhanced prolifera-
tion. More direct evidence, however, and the mechanism by
which DBI affects proliferation is provided by our in vivo cell
cycle experiments, demonstrating that DBI favors progenitor
cell division without affecting cell cycle length.
Previous in vitro studies investigated the involvement of GABA
in neuronal proliferation and showed that it negatively regulates
cell division in embryonic and postnatal progenitors. Thus,
studies on embryonic neocortical explants revealed that GABA
decreases the proliferation of cortical progenitors (LoTurco
et al., 1995) and SVZ cells (Haydar et al., 2000). Furthermore,
in organotypic slices from neonatal rats, activation of GABAA
receptors inhibits cell cycle progression of neuroblasts (Nguyen
et al., 2003). Finally, in organotypic slices from adult mice, GABA
exerts a tonic inhibitory control on the proliferation of SVZ astro-
cyte-like cells (Liu et al., 2005). Interestingly, Tozuka and col-
leagues described that GABA promotes differentiation of hippo-
campal progenitor cells (Tozuka et al., 2005), raising the question
whether similar GABA-mediated mechanisms might regulate
proliferation in the two postnatal neurogenic niches. This is of
note, given that SVZ-derived neurons develop an inhibitory
phenotype while those in the hippocampus become excitatory
neurons. Here we demonstrate that proliferative progenitor cells
in the SVZ express GABAA receptors. Furthermore, we show
in vivo that GABA signaling controls proliferation of transit-
amplifying cells. There is recent in vivo evidence based on phar-
macological approaches that GABA signaling also controls84 Cell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc.proliferation of neural stem cells (Fernando et al., 2011). Here
we used a virus-mediated approach that allowed us to affect
GABAA receptor-mediated activity selectively in progenitors,
thereby circumventing indirect effects that are obtained upon
systemic pharmacological intervention. Most importantly, we
identify a mechanism and show that GABA signaling is modu-
lated by endozepines in the postnatal SVZ. Specifically, we
demonstrate that the DBI-proteolytic product ODN inhibits
GABAA receptor currents recorded from transit-amplifying cells
in acute brain slices. The electrophysiological results most prob-
ably account for the observed effect on increased proliferation
in vivo upon ODN delivery onto neural progenitors.
The downstream signaling mechanism by which GABA
reduces proliferation of transit-amplifying cells remains to be
elucidated. The GABA effect on proliferation in other cell types
has not been deciphered entirely yet, either. It was proposed
that reduced proliferation of embryonic progenitors and striatal
neuroblasts may be induced by intracellular calcium release
triggered by GABAA receptor activation (LoTurco et al., 1995;
Nguyen et al., 2003). In a recent study, downstream GABA
signaling in stem cells has been linked to histone H2AX phos-
phorylation that limited proliferation (Fernando et al., 2011).
However, further investigations are warranted to identify the
intracellular pathways of GABAA receptor signaling in the distinct
cell types of the neurogenic niche.
A role for DBI on cellular proliferation has been proposed for
other cell types in the central nervous system both under normal
and pathological conditions. In vitro, TTN and ODN were shown
to enhance cellular division of cultured rat astrocytes (Gandolfo
et al., 1999, 2000). Interestingly, Alho and colleagues found a
significant increase in DBI expression in different human brain
tumors such as astrocytomas, glioblastomas, and medulloblas-
tomas (Alho et al., 1995; Miettinen et al., 1995), suggesting that
endozepines might be involved in the highly proliferative rate of
neoplastic cells. The same authors reported that astrocytic
tumors express high levels of PBRs (Miettinen et al., 1995) and
also that GABAA receptors were detected in human gliomas
and medulloblastoma cell lines (Codina et al., 2000; Labrakakis
et al., 1998). Hence, both scenarios regarding DBI mechanism
of action through PBRs and CBRs are possible for a putative
role of endozepines on brain tumor proliferation.
The presence of GABA receptors on neuronal progenitors and
the here-described modulation by endozepines imply that exog-
enous ligands may also be effective in altering proliferation.
Indeed, recent in vivo studies on neonatal brain development re-
ported that the GABAA receptor agonists diazepam and pheno-
barbital suppress cell proliferation in several cortical areas and
neurogenesis in the dentate gyrus (Stefovska et al., 2008). Drugs
acting as GABAA receptor modulators are frequently adminis-
tered as tranquilizers, sedatives, or anticonvulsants in pediatric
medicine. However, different response pathways may be acti-
vated in distinct cell types upon systemic delivery of therapeutic
compounds acting on GABAA receptors. Thus, from a clinical
point of view, it is important to understand the multiple effects
of these drugs on postnatal development in order to design a
rational therapeutic treatment. In addition, manipulation of neural
cell proliferation as is desirable in conditions requiring brain
repair or treatment of tumors demands better knowledge of
the cell type-specific action of the employed drugs.
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Animals
We used wild-type C57BL/6 mice (Charles River) and the transgenic
5-HT3A-EGFP mouse line described before (Inta et al., 2008). All animal proce-
dures were according to the Heidelberg University Animal Care Committee
regulations.
Immunostainings
Young pups were killed by decapitation and their brain was removed and fixed
overnight in 4% PFA. 70 mm sections were cut in a vibratome (Leica VT1000S).
Free-floating sections were permeabilized in 0.2% Triton-PBS for 30 min and
blocked in 3%BSA-PBS for at least 30min before incubation with the first anti-
body in 3% BSA-PBS overnight at 4C. After three washes in PBS, sections
were incubated with the secondary antibody in 3% BSA-PBS for 1–2 hr,
washed again in PBS, and mounted. For BrdU/IdU/CldU stainings, sections
were incubated in HCl 1M at 45C for 45 min followed by 15 min in Tris-HCl
10 mM (pH 8) prior to permeabilization and blocking. Primary antibodies
were: rabbit anti-DBI (1:50, Santa Cruz), mouse anti-GFAP (1:500, Sigma),
chicken anti-Nestin (1:200, Novus), mouse anti-Mash1 (1:500, BD PharMin-
gen), chicken anti-EGFP (1:1000, Abcam), rabbit anti-DsRed (1:1000, Clon-
tech Living Colors), rat anti-BrdU (1:500, Accurate), rat anti-BrdU/CldU
(1:250, Abcam), mouse anti-BrdU/IdU (1:2000, BD PharMingen), rabbit anti-
Active Caspase-3 (1:1500, BD PharMingen), and rabbit anti-Ki67 (1:250,
Abcam). Secondary antibodies were: anti-rabbit Cy3 (1:1000, Jackson
Immuno Research Laboratories), anti-rabbit Alexa 647 (1:1000, Invitrogen),
anti-chicken Alexa 488 (1:1000, Invitrogen), anti-mouse Alexa 488 (1:1000,
Invitrogen), anti-mouse Alexa 647 (1:1000, Invitrogen), anti-mouse Alexa 647
highly cross adsorbed (1:2000, Invitrogen), anti-rat Alexa 488 (1:1000, Invitro-
gen), anti-rat Alexa 647 (1:1000, Invitrogen), and anti-rat DyLight 405 (1:500
Jackson Immuno Research Laboratories). The sections were analyzed by
confocal microscopy (Zeiss LSM 700). The specificity of the DBI antibody
was confirmed by the lack of signal in brain sections from DBI knockout
mice (Neess et al., 2011).
Plasmid Construction
shRNA viral vectorswere generated as follows: we first used the pSUPERRNAi
vector system (OligoEngine) to clone specific shRNA sequences against
mouse DBI. DBIa: GCTGTTCATCTACAGTCACTT, DBIb: CCTGTGAGGACA
TAATGC. We next subcloned the shRNA sequence together with H1 promoter
frompSUPER into the retroviral backbone pFB-tdTomato (Stratagene) and into
a murine Moloney leukemia virus-based retroviral vector containing the RSV
promoter driving the expression of EGFP. As a control we used pFB-EGFP
backbone (Stratagene) containing an shRNAscrambled sequence. For overex-
pression constructs, we amplified by PCR the CDS of DBI from amouse cDNA
brain library and cloned it in-frame downstream of an RFP-T2A sequence from
a retroviral vector containing the RSV promoter. The sequence for ODN was
amplified by PCR with DBI clone as a template, adding a stop codon after
the last codon, and cloned in-frame downstream the RFP-T2A sequence as
before. As a control, we used a similar viral vector expressing EGFP instead
of RFP-T2A. For electrophysiological recordings we used a murine Moloney
leukemia virus-based retroviral vector containing RFP driven by the CAG
promoter, kindly provided by Dr. Fred Gage (Salk Institute, San Diego).
Viral Production and Injections
The packaging cell line HEK293was transfectedwith the viral backbone vector
together with the helper plasmids and the viral particles were purified by ultra-
centrifugation. The concentrated viral solutions (106 108 cfu/ml) were titrated
and mixed. P4 pups were injected into the SVZ with 1 ml of viral solution
through a glass micropipette with the following coordinates from bregma:
0.5 anterior, 1.5 lateral, 1.5 ventral. The animals were returned to their mothers
and killed by decapitation after 3–12 days. For proliferation studies, the
animals were injected twice per day with BrdU (Sigma), 30 mg/kg body weight
on the second and third dpi.
Cell Cycle Experiments
For cell cycle exit experiments, mice were injected with IdU (Sigma) (30 mg/kg
body weight) 50 hr after viral injections, and with CldU (Sigma) (30 mg/kg bodyweight) at 12, 14, 16, 18, and 20 hr after IdU injection. With this protocol, we
ensured that, independently of any variation in cell cycle length, all cells would
be labeled with CldU if they divided in the next cycle after IdU injection.
For cell cycle length experiments, mice were injected with IdU (Sigma)
(30 mg/kg body weight) 64 hr after viral injections, followed by a CldU (Sigma)
(30 mg/kg body weight) injection 1.5 hr later, and sacrificed 0.5 hr after the last
injection. This double labeling approach is based on the assumption that all
dividing cells have similar cell cycle length and that their progression through
the cell cycle is asynchronous. Consequently, the ratio of the number of cells in
any two phases of the cell cycle equals the ratio of the length of the two phases
(Nowakowski et al., 1989). Therefore, (the number of cells in S phase)/(the
number of cells leaving S phase) = Ts/ΔT, where ΔT = time during which cells
can incorporate only the first marker. Here ΔT = 1.5 hr, so (double-labeled
IdU+CldU+ cells)/(single-labeled IdU+ cells) = Ts/1.5 hr. For Tc estimations
we performed the same analysis with the following equation: Ts/Tc = Ns/Nc,
where Ns is the number of cells in S phase and Nc is the total number of prolif-
erating cells. Therefore, Ts/Tc = (IdU+CldU+ cells)/(all virally infectedmitotically
active cells). To calculate the number of mitotically active cells, we performed
Ki67 stainings (a marker of proliferating cells in any active phase of the cell
cycle) and quantified the proportion of Ki67+ cells for each group (green and
red infected cells) in six mice. A total of 16 mice were virally infected and
subsequently injected with IdU and CldU. Of these, ten mice were processed
for IdU/CldU stainings and six for Ki67 stainings.
Neurosphere Cultures
The SVZ was microdissected from500 mm-thick coronal sections of P8–P12
mouse brains. Tissues were treated with papain (0.08%)/DNase I (0.001%) for
3 min at 37C to obtain single-cells suspensions, which were cultured at
a density of 100,000 cells/ml in B27 serum-free/Neurobasal media (Invitrogen)
supplemented with glutamine (2 mM), EGF (20 ng/ml), and FGF (20 ng/ml)
(Sigma). Neurospheres were infected with either RFP or RFP-T2A-DBI-
expressing retrovirus at 1 DIV. Six days postinfection, the cultures were incu-
bated with either only media, Flumazenil 1 mM (Sigma), or PK-11195 1 mM
(Sigma) for 48 hr, followed by the addition of BrdU 10 mM (Sigma) to the media
for the last 3 hr prior fixation. Cells were fixed in 4% paraformaldehyde-PBS
and immunostained. For quantifications, the number of BrdU-positive cells
was counted and the neurosphere area was measured with ImageJ software.
Electrophysiology
Brains were removed from deeply anesthetized (isoflurane) P6–P10 mice.
250 mm-thick sagittal slices were cut in 4C solution containing (in mM):
125 NaCl, 25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 2 CaCl2, 1 MgCl2, 25 glucose;
bubbled with 95%O2/5%CO2 (pH 7.4). Whole-cell recordings were performed
with pipettes pulled from borosilicate glass capillaries with a resistance of
6–8 MU when filled with the following solution (in mM): 127.5 KCl, 11 EGTA,
1 CaCl2, 2 MgCl2, 10 HEPES, 2 Mg-ATP, titrated to pH 7.4 with 35 mM KOH
(final osmolarity 290 mOsm). Liquid junction potentials were not corrected.
Fast (200 ms) applications of GABA onto nucleated outside-out patches
were performed every 20 s with theta glass tubing mounted on a piezo trans-
lator. Applications were repeated 5–10 times for each condition (control, ODN,
wash) at a holding potential of 60mV. Application pipettes were tested by
perfusing solutions with different salt concentrations through the two barrels
onto open patch pipettes and recording current changes with 1 and 500 ms
moves of the application pipette. Only application pipettes with current change
20%–80% rise times below 100 ms and with a reasonable symmetrical on- and
offset were used. The application solution contained (in mM): 135 NaCl, 10
HEPES, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5 glucose (pH 7.2). Stimulus delivery
and data acquisition were performed with PatchMaster software (HEKA).
Signals were sampled at 10 kHz and filtered at 3 kHz, and off-line analysis
was performed with Igor Pro (WaveMetrics).
Quantification and Statistical Analysis
For calculations of red/green ratio at different time points, we counted the total
number of infected cells in 7–9 sagittal sections (containing the SVZ) per
animal. All values were normalized to the mean value at 2 dpi. For in vivo prolif-
eration studies, three pictures from theOB for each brain section (nine sections
per animal) were takenwith a 203 objective from a confocalmicroscope (Zeiss
LSM 700) and the percentage of BrdU-positive cells was calculated for theCell Stem Cell 10, 76–87, January 6, 2012 ª2012 Elsevier Inc. 85
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DBI Induces Neurogenesis via GABAA Receptorsgreen, yellow, and red infected neurons. For RMS versus OB quantifications
from virus-infected animals, all sagittal sections where migrating cells could
be observed were used (6–9 brain sections per animal). The number of red
and green cells migrating in the RMS or differentiated in the OB was counted
for each animal. When the total amount of cells per section was less than
500, every cell was counted.When this valuewas higher (due to amore efficient
virus labeling), three pictures were taken in the RMS and three in the OB per
sectionwith a 203 objective lens and the cells from each picturewere counted.
Ratios of red/green cells were calculated per animal and these values were
used for the finalmean group values and statistical tests applications. All values
were normalized to the mean RMS value. For Mash1+ cell quantification,
confocal pictures were taken close to the injection site (one picture per section,
five to eight sections per animal). In all quantifications, double-infected cells
were counted as treated (not control) except for the rescue experiment.
Statistical analyses were performed with GraphPad Prism 5 software. All
data sets were first tested for Gaussian distribution with the Kolmogorov-
Smirnov normality test. We used two-tailed t test or one-way ANOVA (followed
by Tukey’s test or Bonferroni’s Multiple Comparison post hoc analysis) for
parametric data and a Mann-Whitney U test or Kruskal-Wallis test (followed
by post hoc Dunn’s Multiple Comparison test) for nonparametric data.
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